Institutional investors purchased a net $362.7 thousand shares of CCXI during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 50.29% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 68.0 Thousand shares of ChemoCentryx Inc
FIRST QUADRANT LP Bought 23.3 Thousand shares of ChemoCentryx Inc